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Gene array analysis has been widely used to identify genes induced during T cell activation. Our studies identified an
immediate early gene that is strongly induced in response to IL-2 in mouse T cells which we named cysteine- serine-rich
nuclear protein-1 (CSRNP-1). The human ortholog was previously identified as an AXIN1 induced gene (AXUD1). The protein
does not contain sequence defined domains or motifs annotated in public databases, however the gene is a member of a family
of three mammalian genes that share conserved regions, including cysteine- and serine-rich regions and a basic domain, they
encode nuclear proteins, possess transcriptional activation domain and bind the sequence AGAGTG. Consequently we propose
the nomenclature of CSRNP-1, -2 and -3 for the family. To elucidate the physiological functions of CSRNP-1, -2 and -3, we
generated mice deficient for each of these genes by homologous recombination in embryonic stem cells. Although the CSRNP
proteins have the hallmark of transcription factors and CSRNP-1 expression is highly induced by IL-2, deletion of the individual
genes had no obvious consequences on normal mouse development, hematopoiesis or T cell functions. However, combined
deficiencies cause partial neonatal lethality suggesting that the genes have redundant functions.
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INTRODUCTION
The differentiation and functions of T cells are regulated by many
cytokines, including the family of interleukins (IL) sharing the
common cytokine receptor c chain (IL-2, IL-4, IL-7, IL-9, IL-15,
and IL-21). IL-2 plays an essential role in development of
peripheral T cell populations by promoting cell survival and
driving expansion of antigens-stimulated T cells. It also stimulates
proliferation and differentiation of B cells and augments the
cytotoxic activity of NK cells [1,2]. IL-2 is also required for the
generation of a unique population of CD4+CD25+ regulatory T
cells in the thymus [3–5]. Lastly, IL-2 has been proposed to
regulate clonal contraction by sensitizing activated T cells to
undergo activation-induced cell death (AICD) upon TCR re-
stimulation [6–9].
Although the physiological importance of IL-2 signaling is
established from the above studies, many of the IL-2 signaling
events that mediate the responses are unknown. However, the
derivation of Stat5a/b deficient mice demonstrated that this
transcription factor plays a central role in the response of
peripheral T cells to IL-2 [10,11] and thus implicating gene
regulation as a critical event. [12–15]. These studies have
identified a number of genes that are induced by IL-2. For
example, our previous studies have identified genes such as
cytokine inducible SH2 containing protein (CIS), a member of the
SOCS gene family, the cytokine Oncostatin M (OSM) and
GADD45c. The physiological relevance of these target genes has
been explored by deriving mice in which the genes for CIS
(unpublished data), GADD45c [16] and OSM [17] were deleted
and somewhat remarkably none of the deletions had significant
consequences to T cell development or function.
Here, we report on the identification of a novel gene induced by
IL-2 in mouse T cells that we named cysteine- serine-rich nuclear
protein-1 (CSRNP-1). During the course of our studies, the human
orthologue of the gene, AXUD1, was identified in an array
analysis of genes induced in a colon cancer cell line by over-
expression of AXIN1 [18]. As detailed here, CSRNP-1 is
a member of a novel family of genes encoding nuclear proteins
that contain cysteine- and serine-rich domains. Consequently, we
propose the nomenclature CSRNP-1, -2 and -3 for the family. To
explore the physiological functions of the family members, we
generated mice deficient for each of the genes. Remarkably, none
of the deletion of the individual genes resulted in a detectable
phenotypic change. Deletion of all three family members resulted
in neonatal lethality within the first few days of age, suggesting that
the genes have redundant functions.
RESULTS
Identification of a novel IL-2 induced gene
To characterize the mechanisms of IL-2-induced T cell pro-
liferation we sought to identify new IL-2 target genes using an
Affymetrix array chip (Mu19K). Among the genes that were
strongly induced by IL-2 was a new gene that we named cysteine-
serine-rich nuclear protein-1 (CSRNP-1). The ortholog of
CSRNP-1, AXUD1, was previously identified as a gene that is
up-regulated by over-expression of AXIN1 in a human colon
cancer cell line [18]. As confirmed by northern blot analysis
(Fig. 1A), CSRNP-1 is strongly induced by 1 hour following IL-2
stimulation of activated T cells and expression is maintained for up
to 24 hours (data not shown). Inhibition of protein synthesis with
cycloheximide did not prevent the induction but rather enhanced
it.
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The predicted structure of CSRNP-1 is illustrated in Fig. 2B.
Overall the protein does not contain any previously defined
domains. However, the protein contains an amino-terminal region
that is serine-rich and a region of approximately 50 amino acids
that is cysteine-rich. It should also be noted that overall the protein
is serine-rich (15% serine residues). The area between the serine-
and cysteine-rich regions contains a predominance of basic amino
acids that would have a predicted isoelectric point of 10.5. Based
on the overall amino-acid composition, the protein is predicted to
have an isoelectric point of 4.6 and to be a nuclear protein
(PSORT II program) [19], consistent with the data described
below.
A search of the mouse genome database indicated that CSRNP-
1 is a member of a family of three related proteins. As illustrated in
Fig. 2A, there is sequence similarity across the amino-terminal
region of the proteins and includes similarities in the serine- and
cysteine-rich domains as well as the basic regions. The most
striking similarity was within the cysteine-rich regions (Fig. 2C)
which includes 10 positionally conserved cysteine residues. At the
protein level, CSRNP-1 is approximately 40% identical to
CSRNP-2 and CSRNP-3. Fluorescence in situ hybridization
(FISH) analysis confirms the sequence maps localization for the
CSRNP-1, CSRNP-2 and CSRNP-3 genes to mouse chromosome
9 band F3-4, chromosome 15 band F1-3 and chromosome 2 band
C1.3-2 respectively (data not shown). In addition to the mouse
genome, searching of other genomic databases identified three
CSRNP genes in humans and in most vertebrates, while single
genes are present in D. melanogaster (CG4272, also termed
BcDNA:GH09817) and C. elegans (C41D11.3, also termed 1E998
and YK1057). As with the mouse genes, the CSRNP genes of
other species were most similar within the cysteine-rich region
(Fig. 2C). Since AXUD1 induction is not unique to AXIN1 and, as
indicated below, AXUD1 is a member of a structurally related
family of proteins, we propose the more descriptive name of
cysteine- and serine-rich nuclear proteins (CSRNP) for the gene
family.
Northern blot analyses of the expression in various tissues of
the three genes are illustrated in Fig. 3. CSRNP-3 was the most
restricted in its expression with expression of a 2.2 kb transcript
primarily in the brain with lower levels of expression in kidney
and ovary. CSRNP-2 was expressed as a 4.1 kb transcript that
was detected in a number of tissues, especially in thymus, brain
and ovary. Lastly, a CSRNP-1 transcript of 3.2 kb was detected
in all tissues examined. The highest levels of expression were in
the thymus and lung. It should be noted that we detected shorter
transcripts (of approximate 2 kb) for each gene in testes although
the nature of these transcripts was not determined. Since our
interest was the potential role of CSRNP-1 in T cells, we also
compared the expression levels of the family members in T cells
by quantitative RT-PCR. In naive T cells, low levels of
transcripts were detected for CSRNP-1 and –2, while CSRNP-
3 was undetectable. Moreover, anti-CD3 or IL-2 induced
CSRNP-1 transcripts while CSRNP-2 remained unchanged
(Fig. 1B).
CSRNP proteins are potential transcription factors
The biochemical properties of the proteins were determined by
western blot analysis of Flag-tagged versions of each protein
expressed in 293T cells (Fig. 4A). We consistently observed
multiple bands for CSRNP-1 with the predominant forms having
apparent molecular weights of 90 and 100 kDa. Both of these are
larger than the predicted molecular weight (62.5 kDa). In contrast,
CSRNP-2 and CSRNP-3 yielded single bands, migrating at
apparent molecular weights of 80 and 95 kDa respectively, again
larger than the predicted sizes (58.5 kDa and 66 kDa, respective-
ly). The slower than anticipated migration is likely to be due to the
acidic nature of the proteins. The Flag-tagged proteins were also
expressed into NIH-3T3 cells and analyzed by immunofluores-
Figure 1. Expression of CSRNP-1 and -2 in T cells. A) Growth arrested
activated T cells were stimulated with combinations of IL-2 (200 U/mL),
anti-CD3 (0.5 mg/mL) and cycloheximide (20 mg/mL) (CHX) as indicated
in the figure, RNA samples were subject to northern blot analysis for
CSRNP-1 (upper panel). As a loading control, the gel was stained with
ethidium bromide (lower panel) prior to the northern blot analysis B)
Lymphocytes from spleen were stimulated with combinations of IL-2
and anti-CD3 for two hours. Total RNA was used to perform quantitative
real-time RT-PCR with gene specific primers and probes, to CSRNP-1, -2
and -3. Expression level were calculated from a standard curve made of
serially diluted plasmids encoding each genes and normalized to the
amount of ribosomal 18S RNA.
doi:10.1371/journal.pone.0000808.g001
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illustrated (Fig. 4B) the staining of all three family members
overlapped with DAPI staining of DNA indicating nuclear
localization
Since the CSRNP proteins were nuclear, we sought to
determine whether they had transcriptional activity. We designed
fusion proteins with the heterologous DNA-binding domain of
the yeast GAL4 transcription factor and measured luciferase
activity of a GAL4 reporter construct in 293T cells. Among the
three full length proteins, only CSRNP-1 stimulated reporter
activity (Fig. 4C) that was 70-fold higher than control constructs
and 20% of the activity of a fusion protein of the herpes simplex
VP16 transactivation domain. Although full length CSRNP-2
and -3 did not have transactivation activity in 293T, similar
constructs did transactivate in yeast reporter strains (Fig. 4D).
The transactivation domain of CSRNP-1 mapped to the last
ninety amino acids (493 to 583) of CSRNP -1 although lower
activity was present with fragment containing amino acids 382
and 498.
We then explored the possibility that CSRNP proteins possess
DNA-binding activity by using a binding and amplification
approach (SELEX) [20,21]. Table 1 shows the CSRNP-1, -2
and -3 binding sequence determined. For each protein (CSRNP-1,
-2 and -3), a non-palindromic sequence of AGAGTG (or the
complement CACTCT) was identify at a frequency significantly
above random occurrence.
Generation of CSRNP-deficient mice
To determine the physiological function of CSRNP proteins in
vivo, we generated deficient mice for each of the genes. The
details of the targeting constructs are described in Materials and
Methods and depicted in Fig. 5A–C. All three genes have similar
structures and the exon-intron boundaries are at corresponding
positions in the proteins. Because of the lack of information about
functionally important domains, we sought to delete the most
conserved, amino-terminal, portions of the proteins by replacing
genomic sequences with a neomycin resistance cassette. Because
the CSRNP-3 gene spanned over 180 Kbp, a smaller deletion
was used. In all cases the conserved cysteine-rich domain was
deleted. Proper targeting and transmission of the allele was
confirmed by Southern blot analysis (Fig 5D–F). To determine if
the targeting strategies produced null alleles, we raised antisera
against peptides derived from the CRSNP-1, -2 and -3 protein
sequences. Affinity purified antibodies were used to probe western
blots of lysates from wild type and CSRNP deficient tissues. In
each case, specific bands were detected in wild type tissues but
not in tissues from each deficient strain, again the endogenous
proteins migrated much slower than their predicted molecular
Figure 2. Sequence alignment and primary structure analysis of CSRNP proteins. A) Similarity plot from multiple proteins alignment of CSRNP
family proteins. RefSeq from GenBank are as follow: M. musculus (m) CSRNP-1 (NP_695019), H. sapiens (h) AXUD1 (NP_149016), mCSRNP-2
(NP_700456), hCSRNP-2 (NP_110436), mCSRNP-3 (NP_700458), hCSRNP-3 (NP_079245), D. melanogaster CG4272 (NP_608673) and C. elegans
C41D11.3 (NP_491368). The plot represents the running average of the similarity among the sequences based on a multiple sequence alignment
(blosum62 scoring matrix, 10 amino acid comparison windows). The average similarity across the entire alignment is plotted as a dotted line. B)
Schematic representation of the primary structures of CSRNP family members with depiction of particular features. C) Multiple sequence alignment of
the conserved cysteine (arrows) rich motif.
doi:10.1371/journal.pone.0000808.g002
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versions owning to the presence of the tag (Fig. 5G–I). We thus
conclude that the targeting in each mutant strain produced
a functionally null allele.
Analysis of CSRNP deficient mice
Interbreeding of heterozygote mice produced litters containing
mutant mice at the expected Mendelian ratio. CSRNP-1, 2- or 3-
deficient mice were indistinguishable from their wild type and
heterozygote littermates, developed normally and appeared
healthy. Male and female deficient mice are fertile, and females
appropriately nursed their offspring to adulthood. Histological
examination of various organs from CSRNP-deficient mice did
not reveal any abnormalities. Cohorts of deficient mice were
followed for over two years without evidence of increased death
rates (Fig. 6A–C) and there were no differences in the spectrum of
pathologies observed.
The cellularities of hematopoietic tissues (bone marrow, thymus,
spleen, and lymph nodes) of CSRNP-1 deficient mice were
comparable to wild type littermates (data not shown). Flow
cytometry analysis of mature lymphocytes from lymph nodes
(Fig. 7A) and spleen (Fig. 7C) with anti-Thy1.2 and anti-B220
revealed no differences in the number of T- and B cells. Analysis of
developing thymocytes revealed no difference in the proportions of
double-negative (CD4- CD8-), double-positive (CD4+ CD8+), and
single-positive (CD4+ CD8- or CD4-CD8+) cells (Fig. 7B), nor did
we find any difference at any stage of double-negative de-
velopment as measured by staining with anti-CD25 and anti-
CD44, (data not shown) indicating that T cell development is
unaffected by CSRNP-1-deficiency. The numbers of immature B
cells in the bone marrow as measured by anti-IgM and anti-IgD
staining of B220+ cells (Fig. 7E) or by staining with anti-B220 and
anti-CD43 of IgM- cells (data not shown) were also normal.
Analysis of the myeloid compartment with anti-Mac-1 and anti-
Gr-1 did not reveal any effect of CSRNP-1 deficiency in neither
spleen (Fig. 7D) nor bone marrow cells (Fig. 7F). Similarly, the
numbers of Ter119, c-kit, or NK1.1 cells were normal in CSRNP-
1-deficient mice (data not shown). Taken together those results
indicate that CSRNP-1 is not essential for normal mouse
hematopoiesis. Similar analyses were performed with CSRNP-2
and -3 deficient mice, as well as CSRNP-1/-2 double knockouts,
and in every case we failed to observe any impact of CSRNP
deficiency on hematopoiesis.
Since CSRNP-1 is strongly induced by IL-2 in activated T cells,
we examined the ability of CSRNP-1-deficient T cells to
proliferate in response to IL-2. Because, we also detected transcript
for CSRNP-2 in T cells, and because these genes could be
redundant, we also analyzed CSRNP-2
2/2 and CSRNP-1
2/2/
CSRNP-2
2/2 mice. Splenocytes were activated with anti-CD3
and IL-2 and cultured in media containing IL-2 alone. Irrespective
of their genotype, activated T cells proliferated in response to IL-2
for 10 days (Fig 8A). To determine if CSRNP-1 and/or -2
deficiency affect the sensitivity of activated T cells to response to
IL-2, proliferation in response to increasing concentrations of IL-2
was measured by thymidine incorporation. The proliferation of
wild type and knockout T cells was undistinguishable at any
concentration of IL-2 (Fig. 8B).
IL-2 has been shown to promote AICD of T cell upon TCR re-
stimulation [6], so we examined if CSRNP-1 deficiency had any
impact on AICD. Activated T cells were grown in IL-2 for five
days and then restimulated with plate-bound anti-CD3 in the
presence of IL-2. Under those conditions, we found that knockout
activated T cells were as susceptible as wild type to apoptosis,
similarly IL-2 withdrawal also induced cell death to the same
extent in both genotypes (Fig. 8C).
AXIN1, an inducer of CSRNP-1/AXUD1, induces a high
level of apoptosis in spleen and thymus when over-expressed as
a transgene [22]. Since both CSRNP-1 and -2 are constitutively
expressed in thymocytes (Fig. 3), we investigated whether
apoptosis of thymocytes was altered in CSRNP-1/-2 double
knockouts. Wild type and CSRNP-1
2/2/CSRNP-2
2/2 thymo-
cytes were cultured with dexamethasone, agonistic anti-Fas
antibody or received c-irradiation. Dexamethasone and c-
irradiation completely killed double positive thymocytes while
anti-Fas antibody reduced viability by roughly 50% but there was
no significant difference between wild type and CSRNP-1
2/2/
CSRNP-2
2/2 thymocytes (Fig. 8D). Similar results were obtained
with single CSRNP-1
2/2 or CSRNP-2
2/2 thymocytes (data not
shown).
One of the main functions of T cells upon activation is to
produce cytokines, MACS-purified T cells were stimulated with
plate-bounded anti-CD3 for 48 hours then supernatant where
harvested and a few critical cytokines were quantified by multiplex
beads assay (Fig. 8E). Again, there were no differences between
Figure 3. Expression of CSRNP-1, -2 and -3 in mouse tissues. Northern
blot analysis of poly(A)+ RNA from multiple murine tissues were
hybridized with CSRNP-1, -2 and -3 and actin cDNA probes as indicated
on the figure.
doi:10.1371/journal.pone.0000808.g003
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2/2/CSRNP-2
2/2 double knockout T
cells in the level of IFNc, IL-2, -4, -5 and -10 secreted.
CSRNP have potential redundant functions for
perinatal viability
To determine whether the CSRNP genes have redundant
function, we analyzed the offspring, at 3–4 weeks of age, from
the mating of CSRNP-1
+/2, CSRNP-2
+/2, CSRNP-3
2/2 mice
(Fig. 9A). Mice deficient for all three genes were only obtained at
25% of the expected frequencies. Genotyping pups right after
birth, demonstrated that triple knockouts were born at the
expected frequency (Fig. 9B), but the majority died during the
first 48 hours (Fig. 9C), for reasons that were not evident from
overt or histological analysis with the possible exception of lack of
milk uptake (Fig. 9D). Analysis of surviving CSRNP-1, -2 and -3
triple knockouts, indicated that hematopoiesis was not affected
(data not shown). To determine whether CSRNP-1 contributed to
the phenotypes we also analyzed the offspring from CSRNP-1
+/2,
CSRNP-2
2/2, CSRNP-3
+/2 (fig. 9E) and CSRNP-1
+/2,
CSRNP-2
+/2, CSRNP-3
2/2 (fig. 9F) and again, triple knockouts
were obtained at 25% of the expected frequencies. In addition, the
number of observed offspring relative to that expected of CSRNP-
2
2/2, CSRNP-3
2/2, irrespective of the whether they were
CSRNP-1
+/+ or CSRNP-1
+/2, ranged from 25% to 45%,
indicating that deficiency in CSRNP-2 and CSRNP-3 results in
a significant reduction of survival. There is no significant
difference between the survival of CSRNP-2
2/2, CSRNP-3
2/2
and that of the triple mutants, therefore CSRNP-1 is likely to not
contribute to the phenotype.
DISCUSSION
Gene array analysis has been widely used to characterize the
changes in gene transcription in cellular responses. This global
approach to gene expression has the advantage of identifying novel
Figure 4. CSRNP proteins localize to the nucleus and activate transcription. A) CSRNP proteins have an apparent molecular weight higher than the
predicted molecular weight. Flag-tagged version of CSRNP-1, -2 and -3 were ectopically expressed in 293T cells, proteins were analyzed by western
blot with the anti-Flag M2 monoclonal antibodies. B) Immunofluorescence analysis of CSRNP-1, -2 and -3 proteins in NIH-3T3 fibroblasts. CSRNP
proteins were by stained with the anti-Flag M2 monoclonal antibodies and visualized with anti-mouse secondary antibody (red). Nuclei were
visualized by staining DNA with DAPI (blue). C) Transcription activity of CSRNP proteins in 293T cells. Transcriptional activity of CSRNP-1 was
determined by fusing various regions of CSRNP-1 protein to the DNA-binding domain of the yeast GAL4 transcription factor. The constructs were
transfected in 293T cells with a GAL4-luciferase reporter and a CMV-b-galactosidase reporter constructs. Luciferase activities were measured and
normalized to the the b-galactosidase activities. D) Transcription activity of CSRNP proteins in yeast cells. AH109 cells were transformed as indicated
with the CSRNP-1, -2 or -3 GAL4 DNA-binding domain fusions, GAL4p53 (positive control) or GAL4 DNA-binding domain alone (negative control).
Transcription activity of the GAL4 fusions was determine by comparative growth assay of serially diluted AH109 transformed cells onto non-selective
(left) minimal SD base minus tryptophan (TRP) plate or selective (right) SD minus TRP, minus adenine (ADE), minus histidine (HIS) plus 5-Bromo-4-
chloro-3-indolyl-a-D-galactopyranoside (X-a-Gal). The TRP marked plasmid was maintained under selection for tryptophan.
doi:10.1371/journal.pone.0000808.g004
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approach several studies identified AXUD1/CSRNP-1 as differ-
entially regulated. Specifically, it is induced with the over-
expression of AXIN1 potentially implicating the Wnt signaling
pathway. It was identified in a comparative genomics array
approach as an immune function associated gene [23], a PDGF
transcriptional target by microarray-coupled gene-trap mutagen-
esis approach [24], an inducible gene in microglial cells [25],
a doxorubicin induced gene in cardiomyocytes [26] and, as
demonstrated here, an IL-2 induced gene. In addition, the
sequences for all three genes have been deposited in GenBank as
TGF-b induced apoptosis proteins (TAIP). Conversely, AXUD1/
CSRNP-1 has been shown to be down-regulated in microarray
studies in a variety of tumors including lung, liver, colon and
kidney cancers [18], intrahepatic cholangiocarcinomas [27],
pancreatic tumors [28] and breast cancers [29]. Given the wide
range of settings in which the AXUD1/CSRNP-1 gene expression
is either up- or down-regulated, it was important to gain further
insights into the potential physiological functions of the gene.
Beyond the wide range of factors that affect AXUD1/CSRNP-1
expression, the properties of the gene product and its family
members make the CSRNP family of proteins interesting. All are
nuclear proteins with considerable similarity in their DNA
sequence preference for binding to DNA. Although, we have not
defined the domains of the protein that are involved in the DNA
binding activity, the similarity of sequences observed with all three
family members would suggest that it involves a conserved region,
possibly the cysteine-rich or the basic domain.
One of the more definitive approaches to defining gene function
is through the derivation of mouse strains in which the genes are
deleted. However, in the case of the CSRNP family of genes,
derivation of null mutants in mice failed to reveal any obvious
changes in phenotype that could be used to further study function.
Similarly, there is a reported knockdown of the C. elegans gene by
RNA interference that resulted in no obvious phenotype (http://
www.wormbase.org, WBGene00016562) as well as a report of a P
element insertion in the promoter in D. melanogaster that does not
affect viability (http://flybase.org, allele CG4272
KG07402). Based
on the strong induction of CSRNP-1 in peripheral T cells in
response to IL-2, we focused primarily on mice deficient in this
gene. As detailed, there were no changes in T cell development,
the ability to proliferate in response to IL-2, in cytokine production
or in the ability to undergo antigen-induced cell death. We also
examined the ability of the CSRNP-1 deficient mice to respond to
influenza virus infections without observing any changes (data not
shown). Although not induced by IL-2, CSRNP-2 is also expressed
at low levels in peripheral T cells and consequently similar studies
have been done with CSRNP-2 deficient and CSRNP-1/-2 double
deficient mice to explore potential functional redundancy. Pre-
liminary studies indicate that CSRNP-2 deficient mice were more
susceptible to influenza infection (data not shown), but it appears
that it does not affect the generation of influenza virus-specific T
cells. The increased susceptibility is still under investigation. A
mutant allele of AXUD1/CSRNP-1, generated by gene trapping
was recently reported [30], it is associated with a 20% post-natal
lethality and a weakly penetrant reduction of PDGFRa-dependent
skeletal structures. We have analyzed over 300 offspring at
weaning from interbreeding of heterozygote CSRNP-1 mice and
obtained exact mendelian ratios and no evidence of post-natal
lethality. We also did not observed skeletal defects, therefore our
knockout does not support the phenotypes reported.
Deficiencies in both CSRNP-2/-3 or in all family members
produced a partial neonatal lethality within the first 48 hours of
birth. However we have been unable to determine the basis for the
lethality but it may be associated with a reduced vigor or failure to
compete for material support. Histological analysis failed to
identify phenotypic differences consequently the basis for the
partial neonatal lethality is unknown. Therefore the contribution
of CSRNP-1-/- to the phenotype will only be definitively
addressed once the mechanisms of action of the CSRNP proteins
are identified. Also crossing the mutant mice on pure strains might
increase the penetrance of this phenotype and help to identify the
defect.
The lack of any phenotypic consequences of deleting CSRNP-
1, CSRNP-2 or both genes in T cells can be interpreted in
several ways. One possibility is that the genes have critical
functions, but their functions are redundant. Normally re-
dundancy is considered between family members, however in
the case of CSRNP-1 our studies clearly demonstrate that, if
redundancy is the basis for lack of any consequences of deleting
the genes on T cells, the redundancy must be with gene(s)
unrelated to the CSRNP family of genes. Alternatively, the
CSRNP genes may be essential for a cellular response to a specific
set of conditions or factors.
A number of studies have identified AXUD1/CSRNP-1 as
a gene that is down-regulated in a variety of cancer, thus
implicating the gene as a potential tumor suppressor gene, often
considered related to reduced apoptosis. However, deficiencies of
the individual family members failed to show any increase in
cancers. Moreover, in studies of T cells and hematopoietic cells,
we did not detect any reduction in apoptosis as a consequence of
deficiencies of the genes for the individual family members.
Irrespective, as global approaches to gene expression continue to
implicate members of the CSRNP family of genes in various
physiological responses, the availability of strains of mice lacking
Table 1. CSRNP-1, -2 and -3 consensus DNA-binding
sequences.
......................................................................
CSRNP-1, Occured 51/84, E-value=2.8e-033
Position 1 2 3 4 5 6
A 1 0 0 % 0 %1 0 0 % 0 %0 %1 6 %
C 0% 0% 0% 0% 0% 22%
G 0% 100% 0% 100% 0% 55%
T 0% 0% 0% 0% 100% 8%
Consensus A G A G T G
CSRNP-2, Occured 67/67, E-value=3.6e-060
Position 1 2 3 4 5 6
A 72% 3% 70% 11% 0% 0%
C 0% 3% 0% 0% 0% 0%
G 1% 67% 29% 89% 48% 91%
T 27% 27% 0% 0% 52% 9%
Consensus A G A G T G
CSRNP-3, Occured 64/100, E-value=1.8e-042
Position 1 2 3 4 5 6
A 100% 0% 95% 0% 0% 6%
C 0% 0% 0% 0% 0% 30%
G 0% 99% 5% 100% 0% 52%
T 0% 0% 0% 0% 100% 13%
Consensus A G A G T G
Position-specific matrix of the DNA-binding motif obtained by SELEX.
doi:10.1371/journal.pone.0000808.t001
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MATERIALS AND METHODS
T cells assays
Spleens, thymi, or lymph nodes were crushed into single cell
suspensions in PBS containing 2% fetal bovin serum (FBS)
through a 70-mm-pore-size nylon mesh. Bone marrow cells were
obtained by flushing femurs and tibias with the same buffer. Red
blood cells were lysed by addition of buffer (pH 7.2) containing
150 mM NH4Cl, 1 mM KHCO3, and 0.1 mM EDTA; debris
were removed by straining. To activate T cells, single-cell
suspensions (10
6 cells/ml) of naı ¨ve lymphocytes from spleen or
lymph nodes were stimulated with 0.5 mg/ml of anti-CD3 (2C11;
BD Biosciences Pharmingen, San Diego, CA) and 200 U/ml of
recombinant human IL-2 (Chiron Corp. Emeryville, CA) in RPMI
1640 media supplemented with 10% FBS, L-glutamine, penicillin,
streptomycin, sodium pyruvate, nonessential amino acids (all from
Life Technologies), and b-mercaptoethanol (Sigma). To determine
the growth curve of T cells, cells were kept in IL-2-containing
media, counted every second day and were split back to 10
6 cells/
ml. Viable cell counts were determined by trypan blue exclusion
on Vi Cell
TM Beckman Coulter Counter.
For some experiments activated T cells were growth arrested by
overnight IL-2 withdrawal. To assess the proliferative response to
Figure 5. Targeted disruption of CSRNP-1, -2 and -3 in mice. A-C) Schematic representation of the CSRNP-1, -2 or -3 genomic loci and of the
targeting constructs. A) CSRNP-1 (GeneID: 215418), B) CSRNP-2 (GeneID: 207785) and C) CSRNP-3 (GeneID: 77771). Neo, neomycin resistance cassette;
DTA, diphtheria toxin cassette. Position of the probes used for southern blotting and of the primers (P1 to P8, arrow heads) used for PCR-based
genotyping are also shown. D–E) Southern blot analysis of XbaI (D), SacI (E) or XhoI (F) digested genomic DNA from tail biopsies. Blot was hybridizes
with the external probe indicated in (A to C respectively). G–I). Total thymocyte lysates (G–H) or brain homogenates (I) and 293T cells ectopically
expressing Flag-tagged version of CSRNP-1, -2 and -3, were separated on a 7.5% SDS-PAGE. Western blot analysis was carried out with affinity purified
rabbit polyclonal antibodies raised against a peptides derived from CSRNP-1 (G), CSRNP-2 (H) or CSRNP-3(I). Specific signals are indicated by arrows.
doi:10.1371/journal.pone.0000808.g005
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5 cells growth-arrested T cells were plated in triplicate
in individual well of a 96-well round-bottomed plate in 200 mlo f
media with indicated amounts of IL-2. After 48 h of stimulation,
1 mCi of [3H]thymidine (PerkinElmer Life Sciences Inc., Boston,
MA) was added to the culture for another 16 h. Cells were
harvested and incorporated [3H]thymidine was measured as
counts per minute 1450 MicroBetaH Trilux liquid scintillation
detector (PerkinElmer Life Sciences Inc.).
For fluorescence-activated cell sorter (FACS) analysis, cells were
labeled with fluorophor-conjugated monoclonal antibodies (all
from BD Biosciences Pharmingen) directed against Thy1.2 (53-
2.1), B220 (RA3-6B2), CD3 (17A2), CD4 (L3T4), CD8 (53-6.7),
IgM (R6-60.2), IgD (11_26C.2X), NK1.1 (PK136), TCRb (H57-
597), Gr-1 (RB6-8C5) CD11b (Mac-1, M1/70) and Ter119. The
stained cells were then analyzed on a FACSCalibur (Becton
Dickinson) in multi-color mode using CellQuest software.
Pure T cells (.95%) were obtained by negative selection using
magnetic cell sorting. First, splenocytes were labeled with PE-
conjugated antibodies (utilizing a cocktail of anti-B220, anti-Gr-1,
anti-Mac-1, anti-NK1.1 and anti-Ter119). The cells were then
magnetically labeled with anti-PE MicroBeads (Miltenyi Biotech,
Auburn, CA) according to manufacturer’s instructions, before
being loaded on an AutoMACs (Miltenyi Biotech) for the
depletion of labeled cells.
Cytokines were measured on a Bio-Plex
TM (Bio-Rad Labora-
tories Inc., Hercules, CA) following manufacture’s instructions,
using Luminex beads (MiraiBio Inc., CA), and ELISA matched
antibodies pairs (BD Biosciences Pharmingen).
RNA analysis
We compared gene expression of wild type activated T cells (99%
Thy1.2+ and 85% CD8+) that were deprived of IL-2 for 16 h to
activated T cells that were starved and then re-stimulated with
IL-2 for 2 hours. Total RNA was extracted with TRIzolH reagent
according to the manufacturer’s instructions (Invitrogen Corp.,
Carlsbad, CA). We performed a screen using the GeneChipH
Mu19K array (Affymetrix, Santa Clara, CA) (unpublished data).
The genes on this array were based on sequences from The
Institute for Genomic Research (TIGR) databanks (www.tigr.
org).
For Northern blot analysis, total RNA was separated by
formaldehyde gel electrophoresis, and transferred to Hybond-N+
positively charged nylon membrane (Amersham Biosciences
Corp., Piscataway, NJ). The various probes were labeled with
the Rediprime
TM II kit (Amersham Biosciences Corp.) and
hybridization was performed in Rapid-hyb buffer (Amersham
Biosciences Corp) following manufacturer’s instructions. A First-
Choice
TM Northern blot of murine poly(A) RNA (Ambion Inc.,
Austin, TX) was sequentially probed with radiolabeled fragment of
CSRNP-1, -2, -3 and b-actin cDNA.
Figure 6. The longevity of the CSRNP-deficient mice was similar to
the heterozygous and wild type control mice. Kaplan-Meier survival
curves of CSRNP-1 (A), CSRNP-2 (B) and CSRNP-3 (C) littermates mice,
wild type (WT) heterozygous (HET) and homozygous (KO). Curves are
not significantly different, p value .0.5.
doi:10.1371/journal.pone.0000808.g006
Figure 7. Flow cytometric analyses of hematopoietic cells. Lymph
node lymphocytes (A), thymocytes (B), splenocytes (C and D) or bone
marrow cells (E and F) from individual wild type and CSRNP-1 knockout
mice were stained with monoclonal antibodies to B220 and Thy1.2 (A
and C), CD4 and CD8 (B), Mac-1 and Gr-1 (D and F) or IgM and IgD (E).
Data presented are from a pair of littermate representative of more than
5 pairs analyzed.
doi:10.1371/journal.pone.0000808.g007
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PCR reagents (Applied Biosystems, Foster city, CA) following
supplier’s instructions on an ABI Prism
TM7700 sequence detector
(Applied Biosystems). The following forward primer, reverse
primer and probe (in this order) were used for CSRNP1:
TCCGCCGCCGTTTAAAG, ATCGATGGCATCCGCTGT,
FAM- CGGAACTCCAGCCACTGAAAACTTCCA-TAMRA;
for CSRNP2: GGAGGAGAAACTTCACGCCA, ATCGAGTG
TCAAGCCGTCG, FAM- CGGTCCCGTTCTTCGTCAGC
TTCA-TAMRA; for CSRNP3: GATGCTGAGAGAACAC
CTCCG, CCACTTCGGTGTTGTCCAGA and FAM-AC-
CCTGACCGTGGATGACATTTCCG-TAMRA. All amplifica-
tions were performed in duplicate with 100 ng of total RNA. A
standard curves consisting of serial dilutions from 10
1 to 10
6 copy
of plasmids containing each cDNAs were included in every assays.
The determined copy number of CSRNP mRNA was normalized
to the amount of 18S rRNA in each sample (TaqManH Ribosomal
RNA control reagents (Applied Biosystems).
Figure 8. Normal T cells functions in CSRNP-deficient mice. A) Growth curves of wild type, CSRNP-1
2/2, CSRNP-2
2/2 and CSRNP-1
2/2/CSRNP-2
2/2
T cells. Splenocytes were seeded a density of 10
6 cells/ml and stimulated with anti-CD3 and IL-2, thereafter, the cultures were kept in IL-2-containing
media. Viable cell counts were determined by trypan blue staining every 2–3 days and the cells were split back to 10
6 cells/ml. The data shown
represent the average of three animals per genotype. B) Activated T cells grown in the presence of IL-2 for 7 days were IL-2-depreived overnight and
then stimulated with increasing amounts of IL-2 for 48 hours, then DNA synthesis was determined by pulsing with [
3H]thymidine for 16 hours. C)
Activated T cells grown in the presence of IL-2 for 5 days were then stimulated overnight with plate-bound anti-CD3, viability was determined by
trypan blue staining. D) Thymocytes were either gamma-irradiated (IR) with 500 rad or treated with 1 mM of dexamethasone (DEX) or 1 mg/mL anti-
FAS, 20 hours later viability was determined by propidium iodine exclusion using flow cytometry. E) Cytokine secretion by activated T cells. T cells
were purified by MACS and left unstimulated or treated with plate-bound anti-CD3 for 2 days. Thereafter, supernatant were harvested and cytokine
secreted in the media were measured using Bio-Plex technology. There were no significant difference (p.0.05) between any genotypes in any of
these graphs.
doi:10.1371/journal.pone.0000808.g008
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the expected frequency for offspring obtained from CSRNP-1
2/2/CSRNP-2
+/2/CSRNP-3
+/2 breeder pairs at A) 4 weeks and B) birth. C) Kaplan-Meier
survival curves of CSRNP-1
2/2/CSRNP-2
2/2/CSRNP-3
2/2 triple knockouts. D) Normal morphological phenotype of CSRNP-1
2/2/CSRNP-2
2/2/CSRNP-
3
2/2 triple knockout newborn with the exception of the absence of milk in their stomach. E–F) Comparison of the observed distribution of genotypes
to the expected frequency for offspring obtained from CSRNP-1+/2/CSRNP-22/2/CSRNP-3+/2 and CSRNP-1+/2/CSRNP-2+/2/CSRNP-32/2
breeder pairs at 4 weeks, respectively. Chi square test were performed to determine the significance of differences between the expected and
observed distributions.
doi:10.1371/journal.pone.0000808.g009
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We identified one highly regulated probe set corresponding to
TIGR contig accession number TC39688. We used a correspond-
ing EST fragment (IMAGE clones no. 466039, GenBank
accession no. AA031119) as a probe to screen a mouse spleen
59-Stretch Plus cDNA library, (Clonetech Laboratories Inc., Palo
Alto, CA). One positive clone of 2570 bp was isolated, sequence
analysis revealed that it contained a poly A tail and an open
reading frame of 1488 bp, which was latter found to encode
amino acids 89 to 583). 59-RACE was performed using Marathon
cDNA Amplification Kit (Clonetech Laboratories Inc.) on poly
A+ mRNA isolated from activated T cells to generate a full-
length cDNA. Our sequence is essentially the same as the
GenBank RefSeq NM_153287. We first identified CSRNP-2 by
a related mouse EST sequence (BF122209) the IMAGE clone
was ordered from Incyte and sequenced. The complete sequence
(4168 bp) was since deposited in GenBank (BC03595) by the
Mammalian Gene Collection Program Team. We identified
CSRNP-3 genomic sequence corresponding to exon 4 and 5 from
a BAC clone. This sequence was used to design primer to amplify
a full cDNA from a mouse liver library by 59- and 39-RACE, the
sequence obtained is essentially the same as the GenBank RefSeq
NM_153409.
Chromosomal localization
CSRNP-1 –2 and -3 genomic clones were isolated from a W9.5
embryonic stem cell BAC library (Incyte Genomics, St. Louis,
MO) by screening with cDNA probes. BAC clones were identified
and used for chromosomal localization of each gene by
fluorescence in situ hybridization (FISH). The DNA was labeled
with digoxigenin-11-dUTP (Roche Molecular Biochemicals,
Indianapolis, IN), and hybridization was performed essentially as
previously described [31] on metaphase chromosomes derived
from early passage mouse embryonic fibroblasts.
CSRNP targeting vector and generation of
mutant mice
For the CSRNP-1 gene disruption targeting vector, a 9.5 Kbp
XhoI-ApaI genomic fragment was isolated from a BAC clone and
used to construct the targeting vector. A 3.2 Kbp EcoRI fragment
containing exon 3, 4 and the first 72 bp of exon 5 was replaced
with a cDNA encoding the neomycin resistance gene driven by the
thymidine kinase promoter oriented in the direction opposite to
that of CSRNP-1 transcription. For the CSRNP-2 gene disruption
targeting vector, a 2.9 Kbp HindIII-BglII upstream of exon 2 was
subcloned upstream of the neo cassette, and a 5.8 Kbp XhoI
containing part of exon 5 was cloned downstream, in effect
creating a targeting vector, where exons 2, 3, 4 and the first
290 bp of exon 5 are deleted. For the CSRNP-3 gene disruption
targeting vector, a 9 Kbp BamHI genomic fragment was isolated
from a BAC clone and used to construct the targeting vector. A
3.8 Kbp XbaI-ApaI fragment containing exon 5 and the first
203 bp of exon 5 was replaced with a cDNA encoding the
neomycin resistance gene driven by the thymidine kinase
promoter oriented in the opposite direction to that of CSRNP-3
transcription. For all three targeting vector, a cDNA encoding the
diphtheria toxin gene [32] driven by the thymidine kinase
promoter was inserted at the 39of the targeting construct and
was used for negative selection. CSRNP-deficient mice were
generated essentially as previously described [33]. Briefly, 129/SvJ
E14 ES cells were electroporated with 20 mg of linearized
targeting vector and selected with 340 mg/ml of geneticin
(Invitrogen Corp). Southern Blot analysis was performed to
identify clones with proper integration of the targeted allele.
DNA from geneticin-resistant clones was digested with XbaI for
CSRNP-1 clones, SacI for CSRNP-2 clones or XhoI for CSRNP3
clones; and then probed with labeled DNA fragment adjacent to
the targeted region. Clones heterozygous for the mutation were
injected into C57BL/6 blastocyts, which were then implanted into
pseudopregnant females. Heterozygote agouti mice, from chi-
meras passing the mutation through the germ line, were interbred
to produce wild type and CSRNP-deficient littermates on a mixed
129/SvJ/C57BL/6 background. Genotype was routinely de-
termined from tail DNA by PCR using the following primers for
CSRNP-1: wild type allele, P1 (CACCGTCTACTATTTCC-
CACGGTG) and P2 (TACCTTCCACCTCAGCATCTCCAG)
(202 bp) and knockout allele P3 (CTGCGTGCAATCCATC
TTGT) and P4, (GAAGTGCGTCTGAACTCTTGTCTG)
(378 bp); for CSRNP-2: wild type allele, P5 (GGAGGCTGAT-
GAGACACTTC) and P6 (AGGAGAGCACTCCAAGGTAT)
(452 bp) and knockout allele P3 and P5 (375 bp); for CSRNP-3:
wild type allele, P7 (CCTTCCAAGGTGGATCGTATGT) and
P8 (TGGCAGTCCAGTTCCTCCTGTA) (314 bp) and knock-
out allele P3 and P8 (431 bp).
For organ histological analysis, tissues were fixed overnight in
10% buffered formalin (Fisher Scientific). Fixed tissues were
embedded in paraffin, sectioned (10 mm), and stained with
hematoxylin and eosin.
Transfections, western blots and
immunofluoresence
NIH-3T3 and 293T cell were transfected using the classical
calcium phosphate methods. Cell lysates were prepared in
Laemmli sample buffer and separated by SDS-PAGE. Proteins
were transferred to nitrocellulose membranes, blocked with 3%
dry milk in TBST (10 mM Tris [pH 8.0], 150 mM NaCl, 0.1%
Tween 20), incubated at room temperature for 1 h with anti-
FLAGH M2 (Sigma Chemical Co., St-Louis, MO), washed with
TBST, incubated for 1 h with sheep anti-mouse Ig horseradish
peroxidase-conjugated antibody (Amersham Biosciences Corp),
and proteins were visualized with ECL
TM western blotting
detections reagents according to the manufacturer’s instructions
(Amersham Biosciences Corp).
Immunofluorescence was performed on NIH-3T3 transfected
with FLAG tagged versions of the cDNAs. Cells were first fixed to
glass slides for 20 min at 220uC in methanol:acetone (1:1), then
pearmibilized with 0.1% Triton-X100 for 5 min at room
temperature. Slides were then stained with anti-FLAGH M2 and
detected with Alexa FluorH 568 goat anti-mouse antibody
(Molecular Probes Inc, Eugene, OR).
Analysis of transactivation activity was performed as previously
described [34]. Briefly, a series of fusion proteins were generated
by standard molecular biology techniques between CSRNP
proteins and the heterologous GAL4 DNA-binding domain. The
plasmids encoding the fusion proteins were co-transfected with
a control reporter vector CMV-b-galactosidase and a luciferase
reporter construct under the control of GAL4 response elements.
b-galactosidase activity was determined with a chemiluminescent
reporter assay kit (Galacto-Light Plus
TM, Tropix, Bredford, MA),
luciferase activity was measured with luciferase assay system
(Promega, Madison, WI) and normalized to the b-galactosidase
activity, the normalized luciferase values are given as arbitrary
units.
Analysis of transactivation activity in yeast was performed with
the MATCHMAKER Two-Hybrid System (Clontech) according
to manufacture’s instructions. CSRNP-1, -2 and -3 were cloned in
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vector. The plasmids were transformed in the yeast strain AH109
bearing the HIS3, ADE2 and LacZ reporter genes.
Systematic evolution of ligands by exponential
enrichment (SELEX)
SELEX was performed essentially as previously described [20].
Briefly, Flag-tagged versions of each CSRNP proteins were
transfected in 293T cells. For each binding reaction the Flag-
tagged proteins from one 10 cm dish was immunoprecipitated
with Anti-FLAG M2 affinity gel. The immunocomplex was
incubated with an unbiased set of totally degenerate 30 bp
sequence flanked by PCR priming sequences. The random
double-stranded oligonucleotide was: 59-CGCGGATCCTG-
CAGCTCGAGN1-N30-GTCGACAAGCTTCTAGAGCA-39.
The primers for the PCR were as follows: forward, 59-
CGCGGATCCTGCAGCTCGAG-39; reverse, 59- TGCTCTA-
GAAGCTTGTCGAC-3. The bound DNA was amplified by
PCR and the PCR-product used again in a subsequent binding
reaction. Specific binding was obtained after 4 to 6 cycles;
selected binding sites were then cloned into pCR2.1-TOPO
vector (Invitrogen) and sequenced. Sequences trimmed of
primers and vector sequences were used as input for the motif
discovery tools MEME which outputs all motifs present in the
training set.
Rabbit polyclonal antibodies
Peptides corresponding to CSRNP-1 amino acids 36 to 54
(ASSASPAWNSDEEGPGGQA), CSRNP-2 amino acids 484 to
502 (KEPESEDLHPSWSPSSLPF) AND CSRNP-3 amino acids
561 to 581 (GDSHISEHPAENPLSLAEKSR) were synthesized,
conjugated to glutaraldehyde-activated keyhole limpet hemocya-
nin, and used to immunize rabbits (Rockland Immunochemicals,
Inc. Gilbertsville, PA). Before use, antibodies were purified by
affinity chromatography over corresponding peptide columns.
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